Document is current

Any future updates will be listed below

Design, synthesis and pharmacological characterization of N-(3-ethylbenzo[d]isoxazol-5-yl) sulfonamide derivatives as BRD4 inhibitors against acute myeloid leukemia

Crossref DOI link: https://doi.org/10.1038/s41401-022-00881-y

Published Online: 2022-03-09

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark